Interval Partners LP Takes $37.99 Million Position in Bath & Body Works, Inc. (NYSE:BBWI)

Interval Partners LP purchased a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 979,923 shares of the company's stock, valued at approximately $37,992,000. Interval Partners LP owned approximately 0.45% of Bath & Body Works as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Bath & Body Works by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 28,199,787 shares of the company's stock valued at $1,093,306,000 after purchasing an additional 208,036 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its position in Bath & Body Works by 4.3% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 10,235,086 shares of the company's stock valued at $396,815,000 after acquiring an additional 422,973 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Bath & Body Works by 5.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,494,089 shares of the company's stock worth $329,317,000 after acquiring an additional 445,887 shares in the last quarter. Alliancebernstein L.P. lifted its holdings in shares of Bath & Body Works by 35.6% during the fourth quarter. Alliancebernstein L.P. now owns 5,178,447 shares of the company's stock valued at $200,768,000 after acquiring an additional 1,360,264 shares during the period. Finally, Anomaly Capital Management LP lifted its holdings in shares of Bath & Body Works by 38.3% during the fourth quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company's stock valued at $188,456,000 after acquiring an additional 1,346,752 shares during the period. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Up 0.3%

Shares of NYSE:BBWI traded up $0.10 during midday trading on Wednesday, hitting $33.77. The company had a trading volume of 3,640,901 shares, compared to its average volume of 4,819,462. Bath & Body Works, Inc. has a 12 month low of $24.96 and a 12 month high of $52.99. The firm has a fifty day simple moving average of $29.82 and a 200 day simple moving average of $33.86. The stock has a market cap of $7.19 billion, a price-to-earnings ratio of 8.24, a PEG ratio of 0.92 and a beta of 1.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Equities analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works declared that its Board of Directors has authorized a share repurchase program on Thursday, February 27th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 6.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on BBWI shares. The Goldman Sachs Group lowered their target price on shares of Bath & Body Works from $49.00 to $42.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Raymond James dropped their price objective on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a report on Thursday, April 17th. Barclays reduced their target price on Bath & Body Works from $38.00 to $31.00 and set an "equal weight" rating on the stock in a report on Monday. Cowen reaffirmed a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Citigroup reduced their price objective on Bath & Body Works from $48.00 to $36.00 and set a "buy" rating on the stock in a research note on Monday, April 7th. Four research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $41.69.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.